Suppr超能文献

急性缺血性卒中患者收缩期和舒张期心脏功能障碍及心力衰竭的患病率和决定因素:SICFAIL研究

Prevalence and determinants of systolic and diastolic cardiac dysfunction and heart failure in acute ischemic stroke patients: The SICFAIL study.

作者信息

Heuschmann Peter U, Montellano Felipe A, Ungethüm Kathrin, Rücker Viktoria, Wiedmann Silke, Mackenrodt Daniel, Quilitzsch Anika, Ludwig Timo, Kraft Peter, Albert Judith, Morbach Caroline, Frantz Stefan, Störk Stefan, Haeusler Karl Georg, Kleinschnitz Christoph

机构信息

Institute of Clinical Epidemiology and Biometry, University of Würzburg, Josef-Schneider-Str. 2, Würzburg, 97080, Germany.

Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.

出版信息

ESC Heart Fail. 2021 Apr;8(2):1117-1129. doi: 10.1002/ehf2.13145. Epub 2020 Dec 22.

Abstract

AIMS

Ischaemic stroke (IS) might induce alterations of cardiac function. Prospective data on frequency of cardiac dysfunction and heart failure (HF) after IS are lacking. We assessed prevalence and determinants of diastolic dysfunction (DD), systolic dysfunction (SD), and HF in patients with acute IS.

METHODS AND RESULTS

The Stroke-Induced Cardiac FAILure in mice and men (SICFAIL) study is a prospective, hospital-based cohort study. Patients with IS underwent a comprehensive assessment of cardiac function in the acute phase (median 4 days after IS) including clinical examination, standardized transthoracic echocardiography by expert sonographers, and determination of blood-based biomarkers. Information on demographics, lifestyle, risk factors, symptoms suggestive of HF, and medical history was collected by a standardized personal interview. Applying current guidelines, cardiac dysfunction was classified based on echocardiographic criteria into SD (left ventricular ejection fraction < 52% in men or <54% in women) and DD (≥3 signs of DD in patients without SD). Clinically overt HF was classified into HF with reduced, mid-range, or preserved ejection fraction. Between January 2014 and February 2017, 696 IS patients were enrolled. Of them, patients with sufficient echocardiographic data on SD were included in the analyses {n = 644 patients [median age 71 years (interquartile range 60-78), 61.5% male]}. In these patients, full assessment of DD was feasible in 549 patients without SD (94%). Prevalence of cardiac dysfunction and HF was as follows: SD 9.6% [95% confidence interval (CI) 7.6-12.2%]; DD in patients without SD 23.3% (95% CI 20.0-27.0%); and clinically overt HF 5.4% (95% CI 3.9-7.5%) with subcategories of HF with preserved ejection fraction 4.35%, HF with mid-range ejection fraction 0.31%, and HF with reduced ejection fraction 0.78%. In multivariable analysis, SD and fulfilment of HF criteria were associated with history of coronary heart disease [SD: odds ratio (OR) 3.87, 95% CI 1.93-7.75, P = 0.0001; HF: OR 2.29, 95% CI 1.04-5.05, P = 0.0406] and high-sensitive troponin T at baseline (SD: OR 1.78, 95% CI 1.31-2.42, P = 0.0003; HF: OR 1.66, 95% CI 1.17-2.33, P = 0.004); DD was associated with older age (OR 1.08, 95% CI 1.05-1.11, P < 0.0001) and treated hypertension vs. no hypertension (OR 2.84, 95% CI 1.23-6.54, P = 0.0405).

CONCLUSIONS

A substantial proportion of the study population exhibited subclinical and clinical cardiac dysfunction. SICFAIL provides reliable data on prevalence and determinants of SD, DD, and clinically overt HF in patients with acute IS according to current guidelines, enabling further clarification of its aetiological and prognostic role.

摘要

目的

缺血性卒中(IS)可能会引起心脏功能改变。目前缺乏关于IS后心脏功能障碍和心力衰竭(HF)发生率的前瞻性数据。我们评估了急性IS患者舒张功能障碍(DD)、收缩功能障碍(SD)和HF的患病率及决定因素。

方法与结果

“小鼠和人类卒中诱导性心力衰竭(SICFAIL)”研究是一项基于医院的前瞻性队列研究。IS患者在急性期(IS后中位4天)接受了心脏功能的全面评估,包括临床检查、由专业超声心动图医生进行的标准化经胸超声心动图检查以及血液生物标志物的测定。通过标准化的个人访谈收集了人口统计学、生活方式、危险因素、提示HF的症状以及病史等信息。根据当前指南,基于超声心动图标准将心脏功能障碍分为SD(男性左心室射血分数<52%或女性<54%)和DD(无SD的患者中≥3项DD体征)。临床显性HF分为射血分数降低、中等范围或保留的HF。在2014年1月至2017年2月期间,共纳入696例IS患者。其中,有足够SD超声心动图数据的患者纳入分析{n = 644例患者[中位年龄71岁(四分位间距60 - 78岁),61.5%为男性]}。在这些患者中,549例无SD的患者可行DD的全面评估(94%)。心脏功能障碍和HF的患病率如下:SD为9.6%[95%置信区间(CI)7.6 - 12.2%];无SD患者中的DD为23.3%(95% CI 20.0 - 27.0%);临床显性HF为5.4%(95% CI 3.9 - 7.5%),其中射血分数保留的HF亚类为4.35%,射血分数中等范围的HF为0.31%,射血分数降低的HF为0.78%。在多变量分析中,SD和HF标准的满足与冠心病史相关[SD:比值比(OR)3.87,95% CI 1.93 - 7.75,P = 0.0001;HF:OR 2.29,95% CI 1.04 - 5.05,P = 0.0406]以及基线高敏肌钙蛋白T相关(SD:OR 1.78,95% CI 1.31 - 2.42,P = 0.0003;HF:OR 1.66,95% CI 1.17 - 2.33,P = 0.004);DD与年龄较大相关(OR 1.08,95% CI 1.05 - 1.11,P < 0.0001)以及与接受治疗的高血压患者对比未患高血压患者相关(OR 2.84,95% CI 1.23 - 6.54,P = 0.0405)。

结论

相当一部分研究人群存在亚临床和临床心脏功能障碍。SICFAIL研究根据当前指南提供了急性IS患者中SD、DD和临床显性HF的患病率及决定因素的可靠数据,有助于进一步阐明其病因学和预后作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca43/8006617/16eda3b54281/EHF2-8-1117-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验